ARTV vs AMGN: Which Stock is Better?
Side-by-side comparison of Artiva Biotherapeutics Inc and Amgen Inc in 2026
ARTV
Artiva Biotherapeutics Inc
$10.80
AMGN
Amgen Inc
$329.82
Key Metrics Comparison
| Metric | ARTV | AMGN | Winner |
|---|---|---|---|
| Market Cap | $253.10M | $186.87B | AMGN |
| P/E Ratio | N/A | 24.33 | AMGN |
| EPS (TTM) | $N/A | $14.23 | AMGN |
| Revenue Growth | -1.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze ARTV
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARTV or AMGN a better investment?
Comparing ARTV and AMGN: Artiva Biotherapeutics Inc has a market cap of $253.10M while Amgen Inc has $186.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARTV and AMGN?
ARTV (Artiva Biotherapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARTV or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARTV or AMGN?
AMGN has higher revenue growth at 0.1% vs -1.0% for ARTV.
Which company is more profitable: ARTV or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for ARTV.
Which is the larger company: ARTV or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $186.87B compared to $253.10M for ARTV.
Should I buy ARTV or AMGN in 2026?
Both ARTV and AMGN have investment merit. ARTV trades at $10.80 while AMGN trades at $329.82. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARTV and AMGN stock?
Key differences: Market Cap ($253.10M vs $186.87B), P/E Ratio (N/A vs 24.3x), Revenue Growth (-1.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).